pluristem therapeutics inc
(PSTI:NASDAQ CM)
Executive Profile*
Frank C. CarlucciHead of Strategic Business Advisory Board, Pluristem Therapeutics, Inc. |
| Age | Total Calculated Compensation | This person is connected to 136 board members in 15 different organizations across 21 different industries. See Board Relationships |
| 81 | -- |
Background*
Mr. Frank C. Carlucci is a Co-Founder of Frontier Group. Mr. Carlucci serves as Counselor of Center for Strategic and International Studies, Inc.. He served as a Managing Director of The Carlyle Group since 1989. He served as the Chairman of The Carlyle Group from 1993 to 2003. Since 1993, Mr. Carlucci served as the Chairman and Partner of The Carlyle Group and also served as its Vice Chairman and Partner from 1989 to 1993. He served as the Chief Executive Officer and ...
Corporate Headquarters*MATAM Advanced Technology ParkHaifa, -- 31905 Israel Phone: 972 7 4710 7171 Fax: 972 7 4710 7172 Board Members Memberships*Chairman Emeritus Chairman of the Board Former Director Chairman Emeritus Director Trustee Emerities Chairman 1989-N/A Chairman Emeritus 1989-N/A Former Director 1989-N/A Former Director 1989-N/A Former Chairman of the Board 1990-Present Director 1990-N/A Former Director and Member of Compensation & Corporate Governance Committee 1994-N/A Former Director 1995-N/A Former Director 1997-Present Director and Member of Nominating and Corporate Governance Committee 1998-Present Director 2000-Present Director 2006-Present Vice Chairman, Member of Compensation Committee, Member of Audit Committee and Member of Executive Committee 2007-Present Vice Chairman, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee
Education*Unknown/Other Education Harvard Business School BA 1952 Princeton University Honorary Doctorate 1989 University of Scranton
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| PSTI:US | $3.05 USD | 0.00 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Gil Van Bokkelen Ph.D. | Co-Founder, Chairman and Chief Executive Officer Athersys, Inc. | $537.5K |
| Christopher J. Calhoun | Co-Founder, Vice Chairman, Chief Executive Officer, Secretary and Member of Executive Committee Cytori Therapeutics, Inc. | $467.9K |
| Robin L. Smith M.D., MBA,Ro | Executive Chairman and Chief Executive Officer Neostem, Inc. | $775.7K |
| Martin P. Rosendale | Chief Executive Officer, President and Director Cytomedix, Inc. | $409.2K |
| Bernard A. Hausen M.D., Ph.D. | Co-Founder, Chief Executive Officer, President, Chief Medical Officer and Director Cardica Inc. | $416.6K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact PLURISTEM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








